Skip to main content
. 2022 Dec 8;14(24):6037. doi: 10.3390/cancers14246037

Table 2.

Delay in diagnosis and results of further diagnostic and therapeutic pathway of bone neoplasms. The Mann–Whitney U test was used to compare the variables. IQR—interquartile range.

Group I (n = 36)
Median (IQR)		 Group II (n = 51)
Median (IQR)		 p Value
  • -

    General delay in diagnosis (months)Malignant lesions

  • -

    Benign lesions

 7 (3.5–12)
6.5 (3–12)
7.5 (4–11.3)		 10 (4–12)
10 (4–12)
10 (5.5–11.8)		 0.728
0.861
0.692
Patient-related delay (months)
  • -

    Malignant lesions

  • -

    Benign lesions

 1 (1–3)
1 (1–3.5)
1 (1–2.5)		 2 (1–4)
2 (1–4)
1 (0.3–3.8)		 0.619
0.556
0.884
Doctor-related delay (months)
  • -

    Malignant lesions

  • -

    Benign lesions

 5 (2–10)
5 (1.5–9.5)
6 (3.5–16.5)		 3 (1.5–8)
2.5 (1–7.5)
5 (2.5–11)		 0.265
0.544
0.845
Time to perform biopsy (days)
  • -

    Malignant lesions

  • -

    Benign lesions

 6.5 (2–10.3)
5 (2–8)
7 (5–12)		 12 (2–27)
7 (2–26.5)
18 (13–28)		 0.025
0.322
0.063
Time to histopathological result (days)
  • -

    Malignant lesions

  • -

    Benign lesions

 12 (8.5–18)
15 (8–19.5)
10.5 (9.8–14)		 13.5 (9–22.8)
13 (9–21.3)
20 (7–27.3)		 0.450
0.750
0.440
Time to perform surgery (days)
  • -

    Malignant lesions

  • -

    Benign lesions

 95 (38.8–70)
97 (78.5–102.3)
93 (73.5–94)		 104 (48–148.5)
104 (86–147.5)
92.5 (44.8–144.3)		 0.494
0.460
0.859